High low-density lipoprotein cholesterol level is associated with an increased risk of incident early-onset vasomotor symptoms

 

Hye Rin Choi ^{1 2}, Yoosoo Chang ^{3 4 5}, Yejin Kim ¹, Jeonggyu Kang ¹, Min-Jung Kwon ^{1 6}, Ria Kwon ^{1 2}, Ga-Young Lim ^{1 2}, Kye-Hyun Kim ⁷, Hoon Kim ^8, Yun Soo Hong ⁹, Di Zhao ⁹, Juhee Cho ^{1 10 9}, Eliseo Guallar ⁹, Hyun-Young Park ¹¹, Seungho Ryu ^{12 13 14}

 

Affiliations expand

• PMID: 360302998
• DOI: 10.1038/s41598-022-19028-4

Abstract

We investigated the associations between serum lipid profiles and risk of early-onset vasomotor symptoms (VMSs) in premenopausal women. This cohort study comprised 2,540 premenopausal women aged 42-52 years without VMSs at baseline (median follow-up: 4.4 years). VMSs, including hot flashes and night sweats, were assessed using the Menopause-Specific Quality of Life questionnaire (Korean version). Early-onset VMSs were defined as VMSs that occurred premenopause; moderate/severe VMSs were defined as a score of ≥ 3 points (range: 0 to 6, 6 being most bothersome). Cox proportional hazard regression models were used to estimate hazard ratios with 95% confidence intervals (CI) for the development of VMSs across the lipid levels. Higher low-density lipoprotein (LDL) cholesterol levels were positively associated with increased risk of early-onset VMSs. Compared to the < 100 mg/dL LDL group, the multivariable-adjusted hazard ratios (HRs) with 95% confidence intervals (CIs) for incident VMSs were 1.19 (1.03-1.37) and 1.20 (1.03-1.40) in participants with LDL cholesterol levels of 100-129 mg/dL and ≥ 130 mg/dL, respectively (P for trend = 0.027). The multivariable-adjusted HR for incident moderate/severe VMSs was 1.37 (95% CI: 1.08-1.73) in participants with LDL ≥ 130 mg/dL, compared to those with LDL < 100 mg/dL. Meanwhile, triglycerides and total and high-density lipoprotein cholesterol levels were not significantly associated with early-onset VMSs risk in premenopausal women. Premenopausal women with high serum LDL cholesterol concentrations had a higher risk of incident early-onset VMSs. Further studies should confirm our findings and examine whether LDL-lowering interventions reduce the risk of early-onset VMSs among women during menopause transition.